JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2005; 46:994-1001, doi:10.1016/j.jacc.2005.02.094
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoefer, I. E.
Right arrow Articles by Buschmann, I. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoefer, I. E.
Right arrow Articles by Buschmann, I. R.

FOCUS ISSUE: ASPIRIN: STATE-OF-THE-ART PAPER

Aspirin, But Not Clopidogrel, Reduces Collateral Conductance in a Rabbit Model of Femoral Artery Occlusion

Imo E. Hoefer, MD, PhD*,{dagger},{ddagger},*, Sebastian Grundmann, MD*,{dagger}, Stephan Schirmer, MD*,{dagger}, Niels van Royen, MD, PhD§, Benjamin Meder, MD*, Christoph Bode, MD*, Jan J. Piek, MD, PhD§ and Ivo R. Buschmann, MD*,||

* Research Group for Arteriogenesis, Department of Cardiology, University of Freiburg, Freiburg, Germany
{dagger} Perfusion Technologies GmbH, Freiburg, Germany
{ddagger} Department of Experimental Cardiology, UMC, University of Utrecht, Utrecht, the Netherlands
§ Department of Cardiology, AMC, University of Amsterdam, Amsterdam, the Netherlands
|| Humboldt University, Center for Cardiovascular Research, Charité, Berlin, Germany.

Manuscript received August 4, 2004; revised manuscript received January 20, 2005, accepted February 14, 2005.

* Reprint requests and correspondence: Dr. Imo E. Hoefer, UMC Utrecht, G02.523, Heidelberglaan 100, NL-3584 CX Utrecht, the Netherlands. (Email: i.hoefer{at}azu.nl).

OBJECTIVES: The objective of this study was to test the potential of aspirin and clopidogrel to influence collateral artery growth (arteriogenesis).

BACKGROUND: Aspirin and clopidogrel are antiplatelet agents commonly used in the treatment of ischemic cardiovascular disease. Both inhibit platelet aggregation; however, they differ mechanistically because aspirin acts via cyclooxygenase (COX) inhibition, while clopidogrel noncompetitively antagonizes the P2Y12 adenosine diphosphate receptor. We hypothesized that aspirin, due to its anti-inflammatory effects through inhibition of COX activity could inhibit arteriogenesis. Given that clopidogrel does not affect COX activity, it would be less likely to interfere with collateral artery growth.

METHODS: Fifty-four New Zealand White rabbits received either saline, aspirin (10 mg/kg), or clopidogrel (10 mg/kg) for seven days after femoral artery ligation. Maximal collateral conductance was assessed with fluorescent microspheres under maximal vasodilation; cellular migration and proliferation (Ki-67) was evaluated by quantitative immunohistology.

RESULTS: Collateral conductance was significantly reduced by aspirin treatment, whereas clopidogrel had a neutral effect (saline: 0.94 ± 0.04; clopidogrel: 0.94 ± 0.05; aspirin: 0.64 ± 0.03 ml·min–1·100 mm Hg–1·g–1; p < 0.001). Ki-67 proliferation indexes were consistent with these results (saline: 23.1 ± 2.9%; clopidogrel: 23.5 ± 1.1%; aspirin: 19.2 ± 1.1% Ki-67–positive cells). Immunohistochemistry showed COX expression in collateral arteries and a significantly decreased monocyte/macrophage accumulation in the perivascular tissue after aspirin treatment. Cell adhesion molecule expression on monocytes after activation was significantly reduced by aspirin, which might explain the reduced migratory ability.

CONCLUSIONS: In summary, clopidogrel had a neutral effect on natural arteriogenesis. Aspirin significantly inhibited collateral artery growth, probably due to its anti-inflammatory effect. Additional studies are needed to substantiate these results before translation into clinical practice.

Abbreviations and Acronyms
  ADP = adenosine diphosphate
  COX = cyclooxygenase
  Mac-1 = membrane attack complex-1
  LPS = lipopolysaccharide
  LFA-1 = leukocyte functional antigen-1
  MCP = monocyte chemoattractant protein
  NSAID = non-steroidal anti-inflammatory drug




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. Rousseau, M. Tartas, B. Fromy, A. Godon, M.-A. Custaud, J. L. Saumet, and P. Abraham
Platelet inhibition by low-dose aspirin but not by clopidogrel reduces the axon-reflex current-induced vasodilation in humans
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1420 - R1426.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Grundmann, N. van Royen, G. Pasterkamp, N. Gonzalez, E. J. Tijsma, J. J. Piek, and I. E. Hoefer
A New Intra-Arterial DeliveryPlatform for Pro-Arteriogenic Compounds to Stimulate Collateral Artery Growth Via Transforming Growth Factor-{beta}1 Release
J. Am. Coll. Cardiol., July 24, 2007; 50(4): 351 - 358.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Birnbaum, Y. Lin, Y. Ye, J. D. Martinez, M.-H. Huang, C. Y. Lui, J. R Perez-Polo, and B. F. Uretsky
Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2891 - H2897.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2005 by the American College of Cardiology Foundation.